Do you need a license to sell peptides in North Dakota?

It depends on which license you mean, because "peptides" is not a single regulatory category. Any business selling any product faces a commercial layer (entity registration, tax permits, resale documentation) and operating in North Dakota is no exception. Selling something intended for human use as a drug raises an entirely separate and far heavier set of questions that sit with pharmacy and health regulators. Research-use-only (RUO) peptides sold business-to-business occupy a third, narrower lane with its own constraints on labeling, stated intended use, and who you may sell to. Which lane your model actually falls into is a question for your attorney and the relevant North Dakota boards. This article is informational only and is not legal advice.

Three questions wearing one coat

When an operator asks whether they need a license, they are usually collapsing three separate inquiries into one sentence. Untangling them is most of the work.

The first question is whether you are permitted to operate a business at all: a matter of entity formation, registration, and tax collection that applies whether you sell peptides, protein powder, or patio furniture. The second is whether the specific thing you intend to sell is regulated as a drug, an active pharmaceutical ingredient, or a medical product, which pulls in a completely different body of law and a completely different regulator. The third is whether you can lawfully resell material that is labeled and sold for laboratory research use only, and what obligations travel with it.

Those three questions have three different answers, three different authorities, and three different failure modes. An operator who satisfies the first and assumes it covers the other two has not actually cleared anything. The practical move is to write down which of the three your business model triggers, then take each one to the party who can answer it, in writing.

The commercial layer that applies to any product

This is the least interesting part of a peptide business in ND and the part most likely to be handled correctly, because it is the same work any new company does. Expect to confirm entity registration with the North Dakota Secretary of State, sales and use tax registration with the state tax authority, and any local requirements for the municipality where your business is domiciled. Filing requirements and fees change, so confirm the current ones directly with each agency rather than relying on a blog, including this one.

One item in this layer matters more to your supplier relationship than the rest: resale documentation. Legitimate wholesale programs verify that they are selling to a business rather than to an individual consumer, and a resale or exemption certificate is the usual instrument. If a supplier never asks who you are, that tells you something about how they treat every other part of compliance. A wholesale account that requires no verification at all is not doing you a favor.

This layer is also where record-keeping habits get set. Keep your registrations, certificates, supplier agreements, and batch documentation in one place from the first order. If a question ever arrives from a regulator, your counsel's first request will be for exactly that file.

Where drug distribution law enters the picture

This is the question worth spending real money on with an attorney. If a product is intended for human use as a drug, or functions as an active pharmaceutical ingredient, the conversation changes from business registration to drug distribution: a space involving wholesale distributor licensure, pharmacy board oversight, supply chain and pedigree requirements, and federal frameworks governing compounding and drug approval.

Do not assume where your model lands. Ask instead. Reasonable questions to put to your counsel and, where appropriate, to the North Dakota Board of Pharmacy include: based on how I describe, label, and market this product, does the state consider it a drug? Does my activity meet the definition of wholesale distribution in this state? If a licensed practitioner is involved, what does that practitioner's own board say about scope of practice, and does that change my obligations as a supplier? What federal frameworks does my counsel believe apply to how the product is sourced and described?

Notice that every one of those is a question, not a conclusion. Anyone who tells you flatly that selling peptides in North Dakota is permitted, or prohibited, without seeing your specific model, labeling, and customer base is guessing, and you would be inheriting their guess. Intended use is frequently the hinge. The same molecule can sit in very different regulatory positions depending on what is claimed about it, how it is labeled, and who it is sold to.

The research-use-only lane, and what it does not cover

Research-use-only means what it says. RUO peptides are sold for laboratory research. They are not FDA-approved drugs, they are not sold for human or animal consumption, and the framing is not a marketing flourish; it is the boundary of what the material is offered for. Real Peptides supplies compounds on exactly that basis, business-to-business.

What RUO status does is define a legitimate lane for laboratories, research operations, and resellers who serve them. What it does not do is convert into permission for anything downstream. It is not a workaround for drug distribution rules, not a license, and not a shield if a business describes the material in human-use terms. A reseller who buys RUO material and then markets it in the language of therapy has effectively changed the product's stated intended use, and that is precisely the change that draws regulatory attention.

So the honest framing for a buyer is this: your supplier's compliance posture and your compliance posture are two different things. A supplier can label accurately, test rigorously, publish results, and sell only to verified businesses. It cannot make representations about what your business is permitted to do with the material, and you should be skeptical of any supplier that offers to. Your own conduct (your labeling, your claims, your customer base, your record-keeping) belongs to you and your counsel. And if any part of your model touches animal subjects, that question belongs with a licensed veterinarian and your attorney, not with a vendor.

Which question goes to which authority

Build this table for your own business, fill in the answers you receive, and date each entry. It is the single most useful document you can hand to counsel later.

What to verify before you sign with any supplier

Regulatory questions are yours. Supplier diligence is also yours, and it is more tractable. Before you commit volume anywhere, verify the following.

Purity, with a stated method. "High purity" is a word. HPLC with a stated threshold is a measurement. Ask what method was used and what number it produced.

The scope of the test panel. Purity alone is a partial picture. Ask what else is screened, how many parameters the panel covers, and whether testing runs per batch or only on an occasional representative lot.

COA access without friction. Certificates of analysis should be available to you, tied to a batch, and readable before you buy (not sold as an add-on, not emailed after a request escalates, not summarized secondhand). If a supplier treats lab results as a premium feature, assume the results are the reason.

Pricing you can see. Hidden tier structures, quote-only catalogs, and minimums that shift by conversation make it impossible to model a catalog. Margins vary widely by volume and category, and no honest supplier will hand you a projection, but the pricing mechanics themselves should be legible.

Fulfillment origin and lead time. Where does it ship from, and how long does it take? Unclear answers here become stockouts on your shelves.

Documentation that survives scrutiny. Terms of sale, labeling, and test records are what your counsel will read. If they are thin, that is your exposure, not the supplier's.

What Real Peptides does differently

Real Peptides publishes what most of the industry keeps behind a request form. Compounds are tested to 99%+ purity by HPLC, with 7-panel batch testing rather than a single representative lot, and the resulting certificates of analysis are publicly verifiable; a prospective partner can check the lab results directly before opening an account, rather than taking a claim on faith. That verifiability is the point: it means your diligence does not depend on a sales conversation.

Fulfillment is handled in the United States, with orders shipping in five to seven days, which makes inventory planning a schedule rather than a hope. The catalog spans the compounds business buyers ask about most across the popular peptides range, and every listing carries the same research-use-only framing and the same documentation standard.

Access runs through the Wholesale Partner Program, a three-step application: submit your business details, complete verification, and receive partner pricing. Wholesale accounts are for businesses, which is why verification exists at all.

Where that leaves a qualified buyer

If you have taken the licensing questions to your attorney, know which lane your model sits in, and are looking for a supplier whose testing you can check rather than trust, the next step is the qualification path (the Wholesale Partner Program application, where business verification and partner pricing are handled in order).

For more on the topics raised here, see the wholesale peptides program overview, the broader guide to do you need a license to sell peptides, and the page where qualified businesses can apply for a wholesale account.